Clinical Trial Update: Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial [Phase 2]

View source ↗

Summary

Phase II placebo-controlled trial of Paxorol for nocturia has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Paxorol

Snippet

Sponsor: Wellesley Pharmaceuticals, LLC | Conditions: Nocturia | Phase 2 | Status: COMPLETED | Results posted: 2019-06-14